cardiogenesis


Also found in: Dictionary.

cardiogenesis

 [kahr″de-o-jen´ĕ-sis]
development of the heart in the embryo.

car·di·o·gen·e·sis

(kar'dē-ō-gen'ĕ-sis),
Formation of the heart in the embryo.
[cardio + G. genesis, origin]

cardiogenesis

/car·dio·gen·e·sis/ (-jen´ĕ-sis) the development of the heart in the embryo.

cardiogenesis

development of the heart in the embryo.

Patient discussion about cardiogenesis

Q. I developed an AV Fistula after a heart catherization procedure. I am bleeding through the tissues in left arm I am on coumadin, but currently have a lower than usual INR. Corrective surgery was scheduled for yesterday, but had to be delayed. I am concerned that I have a large amount of blood (dark red) bleeding though the tissues right under the skin in my left arm. Should I seek immediate medical attention? The bleeding is over approximately a 3 and 1/2" area on my left arm. Came about in a period of a few minutes.

A. well, you are on blood thinners. i wouldn't take the chance. i mean- i'm not sure i follow what is happening over there. it could be a severe problem or nothing. i would let a doctor check it out. the worse thing that could happen is you wasting a day at the hospital, on the other end of that scenario- you can end up dead. i would go with the first one.

More discussions about cardiogenesis
Mentioned in ?
References in periodicals archive ?
The acquisition of Cardiogenesis adds to the company's portfolio a leading surgical product used in the treatment of diffuse coronary artery disease and severe angina.
In a related but separate matter, CardioGenesis was served, at its California offices, on Friday, September 12, 1997 with a complaint filed by PLC in Munich, Germany alleging that both CardioGenesis and its former German sales agent have infringed EP 553 576, a European counterpart of the '926 patent.
The investigation concerns whether the Cardiogenesis Board of Directors breached their fiduciary duties to Cardiogenesis stockholders by failing to adequately shop the Company before entering into this transaction and whether CryoLife, Inc.
Of those shares tendered, 23,221,166 shares of Cardiogenesis common stock, representing approximately 49.
Cardiogenesis is advancing the TMR therapy with innovative new tools building on the foundation of their flexible fiberoptic delivery system, enabling delivery through small ports in a closed-chest, robotically assisted technique.
In addition, we completed our preclinical work at the Texas Heart Stem Cell Center which included bone marrow compatibility testing as well as a large animal safety study for the PHOENIX(TM) System," said Cardiogenesis Executive Chairman Paul McCormick.
A more detailed description of the Cardiogenesis Board of Directors' recommendation regarding the merger can be found in the Solicitation/Recommendation Statement on Schedule 14D-9 prepared by Cardiogenesis, which was mailed to Cardiogenesis stockholders and which was filed with the Securities and Exchange Commission (SEC) on April 5, 2011.
Based on the PMC's success to date in treating severe chronic angina in Europe, where Cardiogenesis currently has CE Mark approval, we expect that, when approved for use in the U.
2 million related to the Company's proposed acquisition of Cardiogenesis and other business development activities, non-GAAP adjusted net income for the first quarter of 2011 was $2.
April 20, 2011 /PRNewswire/ -- Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will release results for its first quarter ended March 31, 2011 on Wednesday, May 4, 2011.
Before CardioGenesis, Strauss served as director of finance for South San Francisco-based Telik Inc.
NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today announced the expiration of the 20-day "go-shop" period that is part of its definitive agreement with Cardiogenesis Corporation ("Cardiogenesis"), whereby CryoLife is conducting a cash tender offer for 49.